As of 2026-03-19, the Fair Value of Ionis Pharmaceuticals Inc (IONS) is -11.54 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 71.67 USD, the upside of Ionis Pharmaceuticals Inc is -116.11%.
With the market price of 71.67 USD and our fair value calculation, Ionis Pharmaceuticals Inc (IONS) is not a good investment. Investing in IONS stocks now will result in a potential loss of 116.11%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -28.60 | -269.70 | -366.29 | -453.90 | -381.39 | -299.97 |
| YoY growth | 93.56% | -843.01% | -35.81% | -23.92% | 15.97% | -158.64% |
| Market Cap (mil) | 11,839.17 |
| P/E | |
| Forward P/E |
| EPS | -2.31 |
| Avg earnings growth rate | -158.64% |
| TTM earnings | -381.39 |